Cellusion Inc.
PrivateLast Round
Series C
Jun 7, 2023
Total Funding Raised
$34.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellusion Inc. is a regenerative medicine company developing a novel cell therapy product, CLS001, for the treatment of bullous keratopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellusion Inc. Comparables
Compare Cellusion Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SYSTANE | 88% | |
| ActualEyes, Inc. | 84% | |
| Emmecell | 83% |
Cellusion Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 7, 2023 | ||||
| Series B | Jan 7, 2022 | ||||
| Series A | Jan 14, 2020 | ||||
| Grant | May 31, 2019 |
Cellusion Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series B, Series A |
| UTEC (The University of Tokyo Edge Capital Partners) | Series C, Series B |
| New Energy and Industrial Technology Development Organization | Grant |
| Nissay Capital | Series C |
| JIC Venture Growth Investments | Series C |
| Toyo Seikan Group Holdings, Ltd. | Series B |
| Axil Capital Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 57% MoM, from 1.3K to 2K.
- Jun 7, 2023
$21M round led by SPARX Asset Management and Axil Capital Partners.
Cellusion Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellusion Inc.'s valuation, stock price, and market status.
Is Cellusion Inc. a public or private company?
Cellusion Inc. is a private company.
What is the current stock price of Cellusion Inc.?
Cellusion Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Cellusion Inc. worth (valuation)?
Valuation information for Cellusion Inc. is not publicly available.
Can I buy Cellusion Inc. stock?
Cellusion Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellusion Inc.'s last funding round?
Cellusion Inc.'s most recent funding round was Series C on June 7, 2023.
Who are the main investors in Cellusion Inc.?
Key investors in Cellusion Inc. include Keio Innovation Initiative, UTEC (The University of Tokyo Edge Capital Partners), Nissay Capital, JIC Venture Growth Investments, Axil Capital Partners.
Will Cellusion Inc. IPO soon?
No public IPO plans have been announced for Cellusion Inc..
How can I track Cellusion Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellusion Inc.'s secondary market activity and sign up for updates.